Glass Jacobson Investment Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3K Buy
192
+21
+12% +$1.38K ﹤0.01% 447
2026
Q1
$12.2K Hold
171
﹤0.01% 450
2025
Q4
$14K Hold
171
0.01% 430
2025
Q3
$12.9K Sell
171
-30
-15% -$2.24K ﹤0.01% 429
2025
Q2
$14.9K Sell
201
-39
-16% -$2.71K 0.01% 408
2025
Q1
$18.8K Hold
240
0.01% 522
2024
Q4
$18.8K Sell
240
-17
-7% -$1.45K 0.01% 522
2024
Q3
$24.1K Hold
257
0.01% 465
2024
Q2
$20K Buy
257
+26
+11% +$2.12K 0.01% 483
2024
Q1
$21K Buy
231
+65
+39% +$5.41K 0.01% 472
2023
Q4
$12.8K Buy
166
+4
+2% +$280 0.01% 498
2023
Q3
$11K Sell
162
-73
-31% -$5.31K 0.01% 491
2023
Q2
$19.1K Buy
+235
New +$18.8K 0.01% 431
2022
Q4
$0 Buy
+4
New +$230 ﹤0.01% 829

Other funds holding GEHC

Glass Jacobson Investment Advisors's GEHC Position: Q2 2026 in Review

Glass Jacobson Investment Advisors increased its GE HealthCare (GEHC) stake by 12% in Q2 2026, buying an estimated $1.38K and bringing the position to 192 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #447.

Glass Jacobson Investment Advisors first reported a position in GEHC in Q4 2022 and has held it in 14 quarters since. The position peaked at $24.1K in Q3 2024. 833 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Glass Jacobson Investment Advisors held 192 shares of GE HealthCare worth $12.3K as of Q2 2026.
  • Glass Jacobson Investment Advisors bought 21 GE HealthCare shares in Q2 2026, an estimated $1.38K.
  • GE HealthCare made up ﹤0.01% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #447 holding.
  • Glass Jacobson Investment Advisors first reported a position in GE HealthCare in Q4 2022 and has held it in 14 quarters since.
  • Glass Jacobson Investment Advisors's GE HealthCare position peaked at $24.1K in Q3 2024.
  • 833 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.